Clinical Trials Directory

Trials / Conditions / Corticobasal Degeneration

Corticobasal Degeneration

30 registered clinical trials studyying Corticobasal Degeneration10 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDigital Measurements of Motor and Voice Functions in FTD
NCT07333898
BioSensics
RecruitingImaging Studies in Corticobasal Syndrome
NCT07000851
Jennifer Whitwell
RecruitingThe CurePSP Genetics Program
NCT06647641
Massachusetts General Hospital
RecruitingNeurodegenerative Diseases Progression Markers (MARKERS-NDD)
NCT06596746
Casa di Cura San Raffaele Cassino
RecruitingScrambler Therapy for Corticobasal Syndrome-Associated Pain
NCT05653778
Johns Hopkins UniversityN/A
RecruitingThe Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
NCT06174948
Queen Mary University of LondonN/A
Active Not RecruitingA Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
NCT05956834
Massachusetts General Hospital
UnknownUnstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
NCT05638477
Conor FearonN/A
RecruitingNYSCF Scientific Discovery Biobank
NCT06203106
New York Stem Cell Foundation Research Institute
WithdrawntDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study
NCT04883229
University of California, San FranciscoN/A
Active Not RecruitingCommunity Outreach for Palliative Engagement -- Parkinson Disease
NCT05222386
University of RochesterN/A
CompletedNeurological Soft Signs in Neurodegenerative Dementias
NCT06354933
University of Milano Bicocca
Active Not RecruitingSociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register S
NCT06209515
Kuopio University Hospital
CompletedOptimization of Morphomer-based Alpha-synuclein PET Tracers
NCT05067192
Skane University Hospital
CompletedComplex Eye Movements in Parkinson's Disease and Related Movement Disorders
NCT04925622
Saccadous, Inc.
UnknownAutologous Stem/Stromal Cells in Neurological Disorders and Disease
NCT03297177
Regeneris MedicalN/A
CompletedMisfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
NCT04518059
University Hospitals Cleveland Medical Center
UnknownBrain Network Activation in Patients With Movement Disorders
NCT03269201
Sheba Medical Center
CompletedSubcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (AP
NCT04786158
Fondation Ophtalmologique Adolphe de Rothschild
RecruitingThe Swedish BioFINDER 2 Study
NCT03174938
Skane University HospitalN/A
CompletedMore Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
NCT03076671
University of Colorado, DenverN/A
CompletedEarly-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
NCT03153371
University of California, Los Angeles
RecruitingGait Analysis in Neurological Disease
NCT02994719
Beth Israel Deaconess Medical Center
UnknownPROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
NCT02778607
University College, London
CompletedTau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
NCT02167594
Avid RadiopharmaceuticalsPhase 1
CompletedDefining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Ba
NCT02132052
University of Colorado, Denver
RecruitingModifiable Variables in Parkinsonism (MVP)
NCT02194816
Bastyr University
Completed4 Repeat Tauopathy Neuroimaging Initiative
NCT01804452
University of California, San Francisco
CompletedRepetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degener
NCT01174771
University of California, Los Angeles
CompletedA Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
NCT00703677
WestatPhase 1 / Phase 2